ChemBK
  • Home
  • Product Category
  • CHN
  1. Home
  2. CAS 127-07-1
  3. Supplier List
  4. MedChemExpress (MCE)
  5. Signaling Pathways
  6. Hydroxycarbamide

Request for quotation








Supplier Contact

Supplier NameMedChemExpress (MCE)
Contactsales
Tel609-228-6898
Mobile609-228-6898
QQ
Emailsales@medchemexpress.com; tech@medchemexpress.com
Websitehttp://www.medchemexpress.com/
Wechat
Product NameHydroxyurea
SynonymsHU
Hidrix
Hydura
Hydrea
Litaler
Hydurea
Oxyurea

Synonyms

HU
Hidrix
Hydura
Hydrea
Litaler
Hydurea
Oxyurea
sq 1089
Hydreia
Litalir
wr 83799
sk 22591
Hydroxyurea
Biosupressin
Hydroxy urea
Hydroxylurea
Onco-carbide
N-Hydroxyurea
N-HYDROXYUREA
1-hydroxyurea
Carbamoyl oxime
Hydroxycarbamine
Hidroxicarbamida
Hydroxycarbamide
hydrixycarbamide
hydroxy urea (d4)
Carbamyl hydroxamate
Carbamohydroximic acid
Carbamohydroxamic acid
N-Carbamoylhydroxylamine
N-(aminocarbonyl)hydroxylamine
CAS127-07-1
EINECS204-821-7
Chemical FormulaCH4N2O2
Molecular Weight76.05
inchiInChI=1/CH4N2O2/c2-1(4)3-5/h3H2,(H2,2,4)
Package10 mM * 1 mL;500 mg;1 g;5 g
PriceEmail to quote
DescriptionsHydroxyurea

Hydroxyurea

MedChemExpress (MCE)

HY-B0313

127-07-1

Hydroxycarbamide

99.34%

Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month

Room temperature in continental US

Descriptions

Hydroxyurea

Hydroxyurea

MedChemExpress (MCE)

HY-B0313

127-07-1

Hydroxycarbamide

99.34%

Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month

Room temperature in continental US
may vary elsewhere.

Hydroxyurea is a cell apoptosis inducer that inhibit DNA synthesis through inhibition of ribonucleotide reductase. Hydroxyurea shows anti-orthopoxvirus activity.

Hydroxyurea is used in a number of myeloproliferative, neoplastic, HIV, and non-hematological diseases[1]. Treatment of cells in primary culture with 30 μM hydroxyurea for 96 hours significantly increases the fractional HbF content. The Gγ: Aγ-globin mRNA is induced 0.30- to 8-fold in vitro[2]. Hydroxyurea has been shown to block HIV-1 reverse transcription and/or replication in quiescent peripheral blood mononuclear cells and macrophages[3].

Hydroxyurea therapy producs consistent reductions in WBC and ANC without improvement in anemia over 17 weeks. Hydroxyurea at 50mg/kg produces a reduced white blood cell count, absolute neutrophil count and no improvement in anemia compared to vehicle treated sickle cell mice[4].

Mice: To determine whether hydroxyurea would improve anemia and/or prevent or diminish the development of organ damage in the absence of HbF induction, hydroxyurea, at doses of 25 mg/kg, 50 mg/kg, and 100 mg/kg, or vehicle is administered five days per week to SCD mice[4].

HIV-1

| | | |

| | | | | |



[1]. Kovacic P, et al. Hydroxyurea (therapeutics and mechanism): metabolism, carbamoyl nitroso, nitroxyl, radicals, cell signaling and clinical applications. Med Hypotheses. 2011 Jan
76(1):24-31.
[Content Brief]

[2]. Watanapokasin Y, et al. In vivo and in vitro studies of fetal hemoglobin induction by hydroxyurea in beta-thalassemia/hemoglobin E patients. Exp Hematol. 2005 Dec
33(12):1486-92.
[Content Brief]

[3]. Lori F, et al. Rationale for the use of hydroxyurea as an anti-human immunodeficiency virus drug. Clin Infect Dis. 2000 Jun
30 Suppl 2:S193-7.
[Content Brief]

[4]. Lebensburger JD, et al. Hydroxyurea therapy requires HbF induction for clinical benefit in a sickle cell mouse model. Haematologica. 2010 Sep
95(9):1599-603.
[Content Brief]

[5]. M B Slabaugh, et al. Hydroxyurea-resistant vaccinia virus: overproduction of ribonucleotide reductase. J Virol. 1986 Nov
60(2):506-14.
[Content Brief]

Supplier Websitehttp://www.medchemexpress.com/hydroxyurea.html
Last Update2025-10-14 16:03:33
MedChemExpress (MCE) also provides

Thalidomide-4-O-C2-NH2

Category: Signaling Pathways
CAS: 2341840-99-9
Last Update: 2025-10-14 16:03:33

Netupitant N-oxide

Category: Signaling Pathways
CAS: 910808-11-6
Last Update: 2025-10-14 16:03:33

MK-0812

Category: Signaling Pathways
CAS: 624733-88-6
Last Update: 2025-10-14 16:03:33

TS-011

Category: Signaling Pathways
CAS: 339071-18-0
Last Update: 2025-10-14 16:03:33

SCH 530348 sulfate

Category: Signaling Pathways
CAS: 705260-08-8
Last Update: 2025-10-14 16:03:33

BAG 956

Category: Signaling Pathways
CAS: 853910-02-8
Last Update: 2025-10-14 16:03:33

YM758

Category: Signaling Pathways
CAS: 312752-85-5
Last Update: 2025-10-14 16:03:33

Thalidomide-PEG4-NH2

Category: Signaling Pathways
CAS: 2387510-82-7
Last Update: 2025-10-14 16:03:33
  • Home
  • Product Category

© 2015 ChemBK.com All Rights Reserved | Build: 20150530002